Loading...
Therapeutically targeting guanylate cyclase‐C: computational modeling of plecanatide, a uroguanylin analog
Plecanatide is a recently developed guanylate cyclase‐C (GC‐C) agonist and the first uroguanylin analog designed to treat chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS‐C). GC‐C receptors are found across the length of the intestines and are thought to play...
Na minha lista:
| Udgivet i: | Pharmacol Res Perspect |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5368960/ https://ncbi.nlm.nih.gov/pubmed/28357122 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.295 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|